Document is current
Any future updates will be listed below
-
Authors
Tessone, Dean https://orcid.org/0009-0006-0190-9613
Kamal, Mohamed https://orcid.org/0000-0001-8663-8846
Hennes, Valerie
Saadawy, Ahmed H. https://orcid.org/0009-0009-5528-6660
Hwang, E. Shelley https://orcid.org/0000-0002-8571-1148
Nieva, Jorge
Hicks, James https://orcid.org/0000-0001-5353-4338
Kuhn, Peter https://orcid.org/0000-0003-2629-4505
-
Funding
Funding for this research was provided by:
Schlegel Family Endowed Fellowship
USC Norris Comprehensive Cancer Center (P30CA014089)
National Cancer Institute (U01CA285013)
Breast Cancer Research Foundation (BCRF-24-089)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
USC Michelson Center Convergent Science Institute in Cancer
Vassiliadis Research Fund
- License Information
-
More Information
Article History
Received: 28 April 2026
Accepted: 24 June 2026
First Online: 30 June 2026
Declarations
:
: This study used 4 patient blood samples from the OPTImization of blood COLLection (OPTICOLL) study. Informed consent to participate was obtained from all participants in the study. The University of Southern California, University Park Institutional Review Board granted approval for this research (FWA 00007099, USC UPIRB #UP-14-00523). All research was conducted in accordance with the principles of the Declaration of Helsinki. Clinical trial number: not applicable. This study is not a clinical trial.
: Not applicable.
: The authors declare that they have no competing interests.
